SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor

Rheumatoid Arthritis

Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2 - methodology, key messages and justifying information

Rheumatology (Oxford).

Schulze-Koops H, Krüger K, Hoyer BF, Leipe J, Iking-Konert C, Specker C, Commission for Pharmacotherapy and the Board of Directors of the German Society for Rheumatology

doi: 10.1093/rheumatology/keab072.

Immunodeficiency

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Pediatr Allergy Immunol.

Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Focà E, Bezzi M, Baronio B, Giacomelli M, Badolato R

doi: 10.1111/pai.13263.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

J Eur Acad Dermatol Venereol.

Ehsani AH, Nasimi M, Bigdelo Z

doi: 10.1111/jdv.16579.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

J Eur Acad Dermatol Venereol.

Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A

doi: 10.1111/jdv.16732.

Spinal Disorders

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

No abstract available

Further Publications Rheumatology

Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report

Ann Rheum Dis

Golding B, Lee Y, Golding H, Khurana S

doi: 10.1136/annrheumdis-2021-220993

Melanoma and Skin CancerImmunotherapy

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

J Clin Neuromuscul Dis.

Supakornnumporn S, Katirji B

doi: 10.1097/ CND.0000000000000193.

Atopic Dermatitis

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports

J Eur Acad Dermatol Venereol.

Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S

doi: 10.1111/jdv.16527.

Psoriasis

Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab

Ann Dermatol Venereol.

Dubois M, Morel G, Tone A, Gaboriau L, Gautier S, Lazrek M, Vermersch-Langlin A

doi: 10.1016/j.annder.2020.04.020.

Related content

Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2 - methodology, key messages and justifying information

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports

Meningoradiculitis due to varicella zoster virus reactivation in a patient treated with ixekizumab